Nu-Med Plus (NUMD) Cash from Operations (2012 - 2025)
Nu-Med Plus (NUMD) posted Cash from Operations of 35054.0 for Q4 2025, down 207.09% sequentially from 11415.0 in Q3 2025, and down 2001.56% YoY from 1843.44 in Q4 2024.
Nu-Med Plus (NUMD) Cash from Operations (2012 - 2025) Analysis & Trends
Nu-Med Plus has reported Cash from Operations for 14 years, with the latest figure at 35054.0 in Q4 2025.
- Quarterly Cash from Operations fell 2001.56% year-over-year to 35054.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 48137.0 (down 985.88% YoY) and the FY2025 annual result came in at 47979.0, down 982.31% from the prior year.
- Cash from Operations retreated to 35054.0 in Q4 2025 per NUMD's latest filing, from 11415.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 628.0 in Q3 2022 and troughed at 79241.0 in Q1 2021.
- A 5-year average of 21329.53 and a median of 18869.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2023: Cash from Operations jumped 101.53% in 2022, then plunged 3104.62% in 2023.
- Over 5 years, Cash from Operations stood at 20165.0 in 2021, then decreased by 21.17% to 24433.0 in 2022, then soared by 82.47% to 4282.0 in 2023, then surged by 61.05% to 1668.0 in 2024, then tumbled by 2001.56% to 35054.0 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods registered 35054.0, 11415.0, and 1668.0 for Q4 2025, Q3 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn | 1.26 Bn |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn | 651.90 Mn |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn | 269.20 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 168.00 Mn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 437.05 Mn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -35,054.00 |
| Dec 31, 2025 | -35,054.00 |
| Sep 30, 2025 | -11,415.00 |
| Sep 30, 2025 | -11,415.00 |
| Dec 31, 2024 | -1,668.00 |
| Dec 31, 2024 | -1,668.00 |
| Jun 30, 2024 | -2,315.00 |
| Jun 30, 2024 | -2,315.00 |
| Mar 31, 2024 | -450.00 |
| Mar 31, 2024 | -450.00 |
| Dec 31, 2023 | -4,282.00 |
| Dec 31, 2023 | -4,282.00 |
| Sep 30, 2023 | -18,869.00 |
| Sep 30, 2023 | -18,869.00 |
| Jun 30, 2023 | -23,072.00 |
| Jun 30, 2023 | -23,072.00 |
| Mar 31, 2023 | -20,166.00 |
| Mar 31, 2023 | -20,166.00 |
| Dec 31, 2022 | -24,433.00 |
| Dec 31, 2022 | -24,433.00 |